Hikma Injectables USA Inc.

FDA inspection history in Dayton, New Jersey, 2022 to 2025

3
Form 483s

Every document, by year

  • Form 483

2022: one Form 483; 2024: one Form 483; 2025: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2022–25Three Form 483s, at Dayton, New Jersey.
  2. 2024The longest 483 on file: 4 observations over 6 pages at Dayton, New Jersey.

Cited most

Across all Hikma Injectables USA observations on file

The complete Hikma Injectables USA file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2025-08-08483 Form 483$99
2024-06-25483 Form 483$99
2022-06-08483 Form 483$99

FEI number 3022897129 · most recent document Aug 8, 2025

About Hikma Injectables USA Inc.

How many FDA Form 483s has Hikma Injectables USA Inc. received?

FDA Intel has 3 Form 483s on file for Hikma Injectables USA Inc.; the most recent is dated Aug 8, 2025.

When was Hikma Injectables USA Inc. last inspected by FDA?

The most recent FDA inspection document on file for Hikma Injectables USA Inc. is a Form 483 dated Aug 8, 2025, for the site in Dayton, New Jersey.

What did FDA cite at Hikma Injectables USA Inc.?

The regulations cited most in the observations on file for Hikma Injectables USA Inc. are 21 CFR 211.42 (Design and construction features), 5 times; 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time.